Trial record 1 of 1 for:    GOG 0186J
Previous Study | Return to List | Next Study

Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01468909
Recruitment Status : Completed
First Posted : November 10, 2011
Last Update Posted : June 1, 2018
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 27, 2018
  Actual Study Completion Date : January 27, 2018